NCT07062172 Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer Status RECRUITING Phase NA
NCT07059884 Distance-Based Exercise to Preserve Function and Prevent Disability Status RECRUITING Phase NA
NCT07058948 Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors Status RECRUITING Phase PHASE2
NCT07051044 Rapid Absorbance-based Detection of Inner Cheek Cell Abnormalities Using Light Spectroscopy for Risk Evaluation of Lung Cancer to Enable Critical Decision Support in Targeted Patient Populations Status RECRUITING Phase N/A
NCT07049250 Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients Status COMPLETED Phase NA
NCT07049237 Evidence-Based Nursing for Fatigue and Quality of Life in Lung Cancer Chemotherapy Status COMPLETED Phase NA
NCT07048236 Specimen and Clinical Data Collection Plan for LDCT Screening Participants Status RECRUITING Phase N/A
NCT07026110 Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer Status RECRUITING Phase NA
NCT07014878 A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07009769 AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy Status COMPLETED Phase N/A
NCT07008664 Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer Status RECRUITING Phase N/A
NCT06996249 Prospective Data Collection Initiative on Thoracic Malignancies Status RECRUITING Phase N/A
NCT06988579 The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening Status RECRUITING Phase NA
NCT06979661 Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06975384 The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer Status RECRUITING Phase N/A
NCT06973161 ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors Status COMPLETED Phase N/A